首页|舒肝宁注射液临床合理用药及不良反应探讨

舒肝宁注射液临床合理用药及不良反应探讨

扫码查看
目的 分析舒肝宁注射液的不良反应情况以及临床合理用药问题.方法 选择2020年1月-2021年12月收治的使用了舒肝宁注射液治疗的1000例患者作为研究对象,对其用药情况进行回顾性分析,统计对应科室、年龄段,总结临床用药的不合理问题,并分析不良反应发生时间、具体表现.结果 舒肝宁注射液使用率最高的是肝胆外科,占比36.50%,使用年龄段频率最高的是41岁-60岁,占比41.50%,1000例患者中临床用药不合理问题占比最高的是联合用药不适宜(13.10%),其次是未使用说明书推荐溶媒(9.30%),在不良反应时间方面,短则0.5h内,长则7d以上,大多集中在0.5h以内,药物可累及皮肤系统及其黏膜、循环系统以及呼吸系统等,具体表现为丘疹、皮肤瘙痒、胸闷等.结论 舒肝宁注射液的不合理用药问题尚且存在,需要加强用药监控,提高药物使用的合理性.
Discussion on clinical rational use of shuganning injection and its adverse reactions
Objective To analyze the adverse reaction of shuganning injection as well as clinical rational drug use.Methods A total of 1000 cases treated with shuganning injection from January 2020 to December 2021 were selected as the study subjects,and their drug use was retrospectively analyzed.Corresponding departments and age groups were counted,unreasonable problems of clini-cal drug use were summarized,and the occurrence time and specific manifestations of adverse reactions were analyzed.Results The highest usage rate of shuganning injection was at the department of hepatobiliary surgery,accounting for 36.50%,and the highest fre-quency of use was from 41 to 60 years old,accounting for 41.50%.Among 1000 patients,the irrational clinical use of injection ac-counted for the highest proportion of inappropriate combination of drug use(13.10%),followed by the non use of solvent recommended by the instruction manual(9.30%).In terms of adverse reaction time,a short time is 0.5h,the long time is more than 7d,most of them were concentrated within 0.5h,The drug could involve the skin system and its mucosa,circulatory system,as well as the respiratory sys-tem,and the specific manifestations were papules,skin pruritus,chest tightness and so on.Conclusion The problem of unreasonable use of shuganning injection is still open and needs to be strengthened,so as to improve the rational of drug use.

Shuganning InjectionAdverse effectsRational use

王珊珊

展开 >

乌鲁木齐市友谊医院药剂科,乌鲁木齐 830046

舒肝宁注射液 不良反应 合理用药

2024

新疆医学
新疆维吾尔自治区医学会

新疆医学

影响因子:0.385
ISSN:1001-5183
年,卷(期):2024.54(3)
  • 17